Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 1
1963 1
1964 5
1965 1
1966 3
1967 2
1968 2
1969 2
1970 3
1971 3
1972 1
1974 9
1975 5
1976 5
1977 3
1978 4
1979 5
1980 5
1981 9
1982 3
1983 7
1984 8
1985 9
1986 12
1987 5
1988 15
1989 14
1990 19
1991 18
1992 14
1993 13
1994 16
1995 20
1996 24
1997 25
1998 24
1999 38
2000 29
2001 41
2002 43
2003 54
2004 50
2005 41
2006 31
2007 28
2008 35
2009 41
2010 38
2011 58
2012 78
2013 68
2014 39
2015 60
2016 46
2017 68
2018 77
2019 113
2020 109
2021 128
2022 106
2023 91
2024 63
2025 78
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,783 results

Results by year

Filters applied: . Clear all
Page 1
Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of lateral epicondylitis of the humerus - Secondary publication.
Amako M, Arai T, Iba K, Ikeda M, Ikegami H, Imada H, Kanamori A, Namba J, Nishiura Y, Okazaki M, Soejima O, Tanaka T, Tatebe M, Yoshikawa Y, Suzuki K. Amako M, et al. Among authors: yoshikawa y. J Orthop Sci. 2022 May;27(3):514-532. doi: 10.1016/j.jos.2021.09.003. Epub 2021 Dec 16. J Orthop Sci. 2022. PMID: 34922804 Review.
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Among authors: yoshikawa y. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Free article. Clinical Trial.
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy.
Amano M, Kitaoka H, Yoshikawa Y, Sakata Y, Dohi K, Tokita Y, Kato T, Matsushima S, Kitai T, Okada A, Furukawa Y, Tamura T, Hayashida A, Abe H, Ando K, Yuda S, Inoko M, Kadota K, Abe Y, Iwakura K, Kitamura T, Masuda J, Ohara T, Omura T, Tanigawa T, Nakamura K, Nishimura K, Izumi C; REVEAL-HCM Investigators. Amano M, et al. Among authors: yoshikawa y. JACC Heart Fail. 2025 Jun;13(6):1014-1026. doi: 10.1016/j.jchf.2024.12.006. Epub 2025 Mar 12. JACC Heart Fail. 2025. PMID: 40088231 Free article.
Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study.
Kiko T, Asano R, Yoshikawa Y, Endo H, Fujisaki S, Takano R, Akao M, Nishi N, Hayashi H, Ogata S, Kotoku A, Horinouchi H, Inoue Y, Ueda J, Seike Y, Tsuji A, Fukuda T, Nishimura K, Matsuda H, Ogo T. Kiko T, et al. Among authors: yoshikawa y. Eur Respir J. 2025 Jul 14;66(1):2402268. doi: 10.1183/13993003.02268-2024. Print 2025 Jul. Eur Respir J. 2025. PMID: 40049724 Free PMC article.
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Fujimoto S, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: yoshikawa y. Int J Clin Oncol. 2025 Jan;30(1):123-133. doi: 10.1007/s10147-024-02649-2. Epub 2024 Oct 28. Int J Clin Oncol. 2025. PMID: 39467994
Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
Redd MA, Scheuer SE, Saez NJ, Yoshikawa Y, Chiu HS, Gao L, Hicks M, Villanueva JE, Joshi Y, Chow CY, Cuellar-Partida G, Peart JN, See Hoe LE, Chen X, Sun Y, Suen JY, Hatch RJ, Rollo B, Xia D, Alzubaidi MAH, Maljevic S, Quaife-Ryan GA, Hudson JE, Porrello ER, White MY, Cordwell SJ, Fraser JF, Petrou S, Reichelt ME, Thomas WG, King GF, Macdonald PS, Palpant NJ. Redd MA, et al. Among authors: yoshikawa y. Circulation. 2021 Sep 21;144(12):947-960. doi: 10.1161/CIRCULATIONAHA.121.054360. Epub 2021 Jul 15. Circulation. 2021. PMID: 34264749 Free article.
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
Novelli F, Yoshikawa Y, Vitto VAM, Modesti L, Minaai M, Pastorino S, Emi M, Kim JH, Kricek F, Bai F, Onuchic JN, Bononi A, Suarez JS, Tanji M, Favaron C, Zolondick AA, Xu R, Takanishi Y, Wang Z, Sakamoto G, Gaudino G, Grzymski J, Grosso F, Schrump DS, Pass HI, Atanesyan L, Smout J, Savola S, Sarin KY, Abolhassani H, Hammarström L, Pan-Hammarström Q, Giorgi C, Pinton P, Yang H, Carbone M. Novelli F, et al. Among authors: yoshikawa y. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2405231121. doi: 10.1073/pnas.2405231121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990952 Free PMC article.
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
Carbone M, Pass HI, Ak G, Alexander HR Jr, Baas P, Baumann F, Blakely AM, Bueno R, Bzura A, Cardillo G, Churpek JE, Dianzani I, De Rienzo A, Emi M, Emri S, Felley-Bosco E, Fennell DA, Flores RM, Grosso F, Hayward NK, Hesdorffer M, Hoang CD, Johansson PA, Kindler HL, Kittaneh M, Krausz T, Mansfield A, Metintas M, Minaai M, Mutti L, Nielsen M, O'Byrne K, Opitz I, Pastorino S, Pentimalli F, de Perrot M, Pritchard A, Ripley RT, Robinson B, Rusch V, Taioli E, Takinishi Y, Tanji M, Tsao AS, Tuncer AM, Walpole S, Wolf A, Yang H, Yoshikawa Y, Zolondick A, Schrump DS, Hassan R. Carbone M, et al. Among authors: yoshikawa y. J Thorac Oncol. 2022 Jul;17(7):873-889. doi: 10.1016/j.jtho.2022.03.014. Epub 2022 Apr 21. J Thorac Oncol. 2022. PMID: 35462085 Free PMC article. Review.
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial.
Izumi C, Amano M, Yoshikawa Y, Fukushima S, Yaku H, Eishi K, Sakaguchi T, Ohno N, Hiraoka A, Okada K, Saiki Y, Miura T, Komiya T, Minami M, Yamamoto H, Omae K; ENBALV Trial Investigators. Izumi C, et al. Among authors: yoshikawa y. Circ Cardiovasc Interv. 2025 Jul;18(7):e015108. doi: 10.1161/CIRCINTERVENTIONS.124.015108. Epub 2025 May 12. Circ Cardiovasc Interv. 2025. PMID: 40663622 Clinical Trial.
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Komura K, Hirosuna K, Tokushige S, Tsujino T, Nishimura K, Ishida M, Hayashi T, Ura A, Ohno T, Yamazaki S, Nakamori K, Kinoshita S, Maenosono R, Ajiro M, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Konuma T, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: yoshikawa y. Mol Cancer. 2023 Nov 18;22(1):185. doi: 10.1186/s12943-023-01897-6. Mol Cancer. 2023. PMID: 37980528 Free PMC article.
1,783 results